Anlotinib plus irinotecan or docetaxel in small-cell lung cancer (SCLC) relapsed within six months: Updated results from a single-arm, phase II studyMinna Zhang,Xueqin Chen,Hong Jiang,Jiaoli Wang,Jian Ye,Shenglin Ma,Bing XiaANNALS OF ONCOLOGY(2023)引用 2|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要